Tom van Wezel
Overview
Explore the profile of Tom van Wezel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
4132
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jantus-Lewintre E, Rappa A, Ruano D, van Egmond D, Gallach S, Gozuyasli D, et al.
Mol Diagn Ther
. 2025 Jan;
29(2):249-261.
PMID: 39798063
Background: Predicting response to targeted cancer therapies increasingly relies on both simple and complex genetic biomarkers. Comprehensive genomic profiling using high-throughput assays must be evaluated for reproducibility and accuracy compared...
2.
Jentus M, Bakker L, Verstegen M, Pelsma I, van Wezel T, Ruano D, et al.
Endocr Relat Cancer
. 2024 Oct;
32(1.
PMID: 39441837
The molecular biology of pituitary neuroendocrine tumors (PitNETs) revealed few recurrent mutations and extensive chromosomal alterations, with the latter being the driving force in a subset of these lesions. Addressing...
3.
van der Werft Lam A, Helderman N, Boot A, Terlouw D, Morreau H, Mei H, et al.
Exp Mol Pathol
. 2024 Oct;
140:104940.
PMID: 39437510
Functional analyses are the main method to classify mismatch repair (MMR) gene variants of uncertain significance (VUSs). However, the pathogenicity remains unclear for many variants because of conflicting results between...
4.
Kemps P, Woei-A-Jin F, Quint K, van den Bos C, Naeije L, van Laar J, et al.
Blood Adv
. 2024 Oct;
9(3):439-444.
PMID: 39361730
No abstract available.
5.
Kemps P, Baelde H, Vorderman R, Stelloo E, Swennenhuis J, Szuhai K, et al.
Blood
. 2024 Sep;
144(23):2439-2455.
PMID: 39316650
Juvenile xanthogranuloma (JXG) is a histiocytic neoplasm that usually presents in the skin. Rarely, extracutaneous localizations occur; the genetic drivers of this clinical variant of JXG remain incompletely characterized. We...
6.
Schubert S, Ruano D, Joruiz S, Stroosma J, Glavak N, Montali A, et al.
Nat Commun
. 2024 Sep;
15(1):8208.
PMID: 39294166
Germline and somatic TP53 variants play a crucial role during tumorigenesis. However, genetic variations that solely affect the alternatively spliced p53 isoforms, p53β and p53γ, are not fully considered in...
7.
Terradas M, Schubert S, Viana-Errasti J, Ruano D, Aiza G, Nielsen M, et al.
Eur J Hum Genet
. 2024 May;
32(7):871-875.
PMID: 38778081
Two independent exome sequencing initiatives aimed to identify new genes involved in the predisposition to nonpolyposis colorectal cancer led to the identification of heterozygous loss-of-function variants in NPAT, a gene...
8.
van der Sluis K, van Sandick J, Vollebergh M, van Dieren J, Hugen N, Hartemink K, et al.
Oncogene
. 2024 Apr;
43(24):1877-1882.
PMID: 38654110
Detection of peritoneal dissemination (PD) in gastric cancer (GC) patients remains challenging. The feasibility of tumor-guided cell-free DNA (cfDNA) detection in prospectively collected peritoneal fluid (ascites and peritoneal lavage) was...
9.
Freiberger S, Ikenberg K, van Egmond D, Claerhout S, van Wezel T, Vanden Bempt I, et al.
Cancer Cytopathol
. 2024 Apr;
132(7):435-446.
PMID: 38563876
Background: Diagnosis of salivary gland neoplasms is challenging, especially on cytological specimens acquired by fine-needle aspiration. The recently implemented standardized Milan system for reporting salivary gland cytopathology provides an estimated...
10.
Terlouw D, Boot A, Ducarmon Q, Nooij S, Suerink M, van Leerdam M, et al.
BMC Cancer
. 2024 Jan;
24(1):104.
PMID: 38238650
Background: Colibactin, a genotoxin produced by polyketide synthase harboring (pks) bacteria, induces double-strand breaks and chromosome aberrations. Consequently, enrichment of pksEscherichia coli in colorectal cancer and polyposis suggests a possible...